Aleva Neurotherapeutics
Better therapies for a broad range of neurological diseases
Total raised
€48M
€48,266,363
Funding rounds
5
Investors
2
distinct backers
Active since
2011-07
latest 2017-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 5 rounds raised
- ▲ €30M+ raised
- ▲ 18y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-10-03 | Series D+ | €12M | Forrestal Capital | View deal → |
| 2016-05-01 | Series C | €16M | Banexi Ventures | View deal → |
| 2014-05-01 | Series B | €7.3M | — | View deal → |
| 2012-04-01 | Series B | €3.3M | Banexi Ventures | View deal → |
| 2011-08-01 | Series A | €9.5M | — | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy